Use of Probiotic Yogurt in the Treatment of Acute Diarrhea in Children
1 other identifier
interventional
54
1 country
1
Brief Summary
The purpose of this study is to determine the effect of probiotic yogurt in acute watery diarrhea in children. The investigators will compare the effect of two different probiotics products.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Feb 2011
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
October 29, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2012
CompletedFirst Posted
Study publicly available on registry
March 27, 2012
CompletedMarch 27, 2012
March 1, 2012
6 months
October 29, 2011
March 26, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Duration of diarrhea
participants will be followed for the duration of hospital stay, an expected average of 5 days
five days
Secondary Outcomes (3)
Duration of fever
five days
duration of vomiting
five days
duration of hospitalization
five days
Study Arms (2)
probiotic
PLACEBO COMPARATORProbiotic product with Sacharomices Boulardii
probiotic yogurt
ACTIVE COMPARATORYogurt with Lactobacilus Rhamnonsus strain spp
Interventions
Lactobacilus Rhamnonsus 100000000 UFC per mL. Dosage 50 mL twice daily fo 5 days.
Lyophilized probiotic, containing 250 mg per sachet dosage to about 2 times a day for 5 days.
Eligibility Criteria
You may qualify if:
- All acute diarrhea
You may not qualify if:
- Severe malnourishment
- Severe dehydration
- Systemic infections
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centro Pediatrico Albina Patino
Cochabamba, Departamento de Cochabamba, 0866, Bolivia
Study Officials
- PRINCIPAL INVESTIGATOR
Giuseppe E Grandy, MD MSc
Centro Pediatrico Albina Patino
- STUDY DIRECTOR
Richard M Soria, MD
Centro Pediatrico Albina Patino
- STUDY CHAIR
Sdenka Jose, MD
Centro Pediatrico Albina Patino
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Teaching and Research chief
Study Record Dates
First Submitted
October 29, 2011
First Posted
March 27, 2012
Study Start
February 1, 2011
Primary Completion
August 1, 2011
Study Completion
February 1, 2012
Last Updated
March 27, 2012
Record last verified: 2012-03